NCT03501433View on ClinicalTrials.gov

Effects of Nicotinamide Riboside on Metabolism and Vascular Function

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
AgingLipemia
Interventions
DIETARY_SUPPLEMENT

Nicotinamide riboside chloride (Niagen)

250 mg capsules 2x/day for 7 days

DIETARY_SUPPLEMENT

Placebo

2x/day for 7 days

Trial Locations (1)

50011

Iowa State University, Ames

All Listed Sponsors
lead

Iowa State University

OTHER

NCT03501433 - Effects of Nicotinamide Riboside on Metabolism and Vascular Function | Biotech Hunter | Biotech Hunter